CDC25B and colorectal cancer: Significantly higher levels of CDC25B-specific IgG antibodies were observed in patients with colorectal cancer (median, 0.28 μg/ml; range, 0.01-3.34 μg/ml) as compared to volunteer donors (median, 0.20 μg/ml; range, 0.1-0.61 μg/ml; p=0.041; Figure 1A).